LTIP959A - An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof - Google Patents

An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof

Info

Publication number
LTIP959A
LTIP959A LTIP959A LTIP959A LTIP959A LT IP959 A LTIP959 A LT IP959A LT IP959 A LTIP959 A LT IP959A LT IP959 A LTIP959 A LT IP959A LT IP959 A LTIP959 A LT IP959A
Authority
LT
Lithuania
Prior art keywords
acyclovir
ester
salt
guanine
methyl
Prior art date
Application number
LTIP959A
Inventor
Knud Erik Gebhard-Hansen
Soeren Bols Pedersen
Karen Bjoernsdottir
Bodil Gyllembourg Lissau
Boerge Ingvar Frisch Alhede
Original Assignee
Gea Farmaceutisk Fabrik As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gea Farmaceutisk Fabrik As filed Critical Gea Farmaceutisk Fabrik As
Publication of LTIP959A publication Critical patent/LTIP959A/en
Publication of LT3056B publication Critical patent/LT3056B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An antivirally active pharmaceutical oil-in-water emulsion containing 9-[(2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof as an active ingredient in the continuous aqueous phase, said phase in addition to said active ingredient and the dispersed oil phase containing a water miscible organic solvent, wherein a polyhydric alcohol may form a constituent. The emulsion comprises from 1 % to 10 % w/w of acyclovir or a salt or ester thereof, from 20 % to 50 % w/w of organic solvent comprising from 5 % to 50 % w/w glycerol formal and from 0 % to 29 % w/w of a polyhydric alcohol, and from 20 % to 40 % w/w water, said percentages being based on the total weight of the formulation. As a polyhydric alcohol propylene glycol may be used, and the emulsion may be available as a cream, wherein the oil phase comprises white vaseline, liquid paraffin (paraffin oil), glycerol monostearate, and stearic acid.
LTIP959A 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof LT3056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK111392A DK169121B1 (en) 1992-09-09 1992-09-09 Antivirally active pharmaceutical oil-in-water emulsion containing 9 - [(2-hydroxyethoxy) methyl] guanine (acyclovir) or a salt or ester thereof

Publications (2)

Publication Number Publication Date
LTIP959A true LTIP959A (en) 1994-05-15
LT3056B LT3056B (en) 1994-10-25

Family

ID=8101156

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP959A LT3056B (en) 1992-09-09 1993-09-09 An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof

Country Status (27)

Country Link
EP (1) EP0662819B1 (en)
JP (1) JPH08501089A (en)
AT (1) ATE137113T1 (en)
AU (1) AU4945393A (en)
BG (1) BG62032B1 (en)
BR (1) BR9307024A (en)
CA (1) CA2142493A1 (en)
CZ (1) CZ284007B6 (en)
DE (1) DE69302396T2 (en)
DK (1) DK169121B1 (en)
EE (1) EE03088B1 (en)
ES (1) ES2086235T3 (en)
FI (1) FI112777B (en)
GR (1) GR3019984T3 (en)
HR (1) HRP931160B1 (en)
HU (1) HUT72606A (en)
LT (1) LT3056B (en)
LV (1) LV10912B (en)
NO (1) NO308234B1 (en)
PL (1) PL172663B1 (en)
RO (1) RO113306B1 (en)
RU (1) RU2128503C1 (en)
SI (1) SI9300469A (en)
SK (1) SK280119B6 (en)
UA (1) UA41897C2 (en)
WO (1) WO1994005258A1 (en)
ZA (1) ZA936661B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416674C2 (en) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topical preparation containing acyclovir
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
AU2004202929B2 (en) * 1999-09-22 2006-11-23 B. Ron Johnson Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores
WO2005067941A1 (en) * 2004-01-08 2005-07-28 Universidad De Concepcion Topical aciclovir formulation
CA2563678A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20050257718A1 (en) * 2004-05-22 2005-11-24 Engelhard Corporation Natural Pearl in Butylene Glycol
WO2007121318A2 (en) * 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
WO2008006085A2 (en) * 2006-07-07 2008-01-10 University Of Washington Compositions and methods for predicting inhibitors of protein targets
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
MX337166B (en) 2009-06-24 2016-02-15 Topical composition containing ibuprofen.
CN105920603B (en) 2010-12-29 2022-02-11 战略科学与技术有限责任公司 Treatment of erectile dysfunction and other indications
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
FR3023718B1 (en) * 2014-07-16 2018-10-12 Pierre Fabre Medicament PHARMACEUTICAL AND / OR COSMETIC COMPOSITIONS DECONTAMINATED BY HIGH PRESSURE
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
GB2080106B (en) * 1980-07-18 1984-03-07 Weelcome Foundation Ltd Acyclovin preparations

Also Published As

Publication number Publication date
EP0662819A1 (en) 1995-07-19
NO308234B1 (en) 2000-08-21
PL307860A1 (en) 1995-06-26
NO950895L (en) 1995-03-08
FI951086A (en) 1995-03-08
DK111392A (en) 1994-03-10
BR9307024A (en) 1999-06-29
BG99484A (en) 1995-12-29
GR3019984T3 (en) 1996-08-31
DE69302396D1 (en) 1996-05-30
LV10912A (en) 1995-12-20
DK169121B1 (en) 1994-08-22
HRP931160A2 (en) 1995-12-31
RU95110930A (en) 1997-03-27
CZ59995A3 (en) 1995-09-13
LV10912B (en) 1996-08-20
DK111392D0 (en) 1992-09-09
PL172663B1 (en) 1997-10-31
SK280119B6 (en) 1999-08-06
FI951086A0 (en) 1995-03-08
DE69302396T2 (en) 1996-08-14
CZ284007B6 (en) 1998-07-15
LT3056B (en) 1994-10-25
ES2086235T3 (en) 1996-06-16
HRP931160B1 (en) 1999-04-30
RO113306B1 (en) 1998-06-30
EP0662819B1 (en) 1996-04-24
BG62032B1 (en) 1999-01-29
NO950895D0 (en) 1995-03-08
SK29195A3 (en) 1997-01-08
ZA936661B (en) 1994-05-20
CA2142493A1 (en) 1994-03-17
SI9300469A (en) 1994-03-31
WO1994005258A1 (en) 1994-03-17
ATE137113T1 (en) 1996-05-15
HU9500702D0 (en) 1995-04-28
JPH08501089A (en) 1996-02-06
AU4945393A (en) 1994-03-29
FI112777B (en) 2004-01-15
EE03088B1 (en) 1998-06-15
HUT72606A (en) 1996-05-28
UA41897C2 (en) 2001-10-15
RU2128503C1 (en) 1999-04-10

Similar Documents

Publication Publication Date Title
LTIP959A (en) An antivirally active pharmaceutical oil-in-water emulsion containing 9-£(2-hydroxy-ethoxy)methyl|guanine (acyclovir) or a salt or ester thereof
US4963555A (en) Formulations of heterocyclic compounds
KR890006213A (en) Photoprotective composition containing tocopherol sorbate
IE811617L (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine
FR2706298B1 (en) Cosmetic or dermatological composition in the form of a stable oil-in-water emulsion containing at least one vegetable oil consisting of at least 40% of linoleic acid triglycerides.
CA2074503C (en) Pharmaceutical formulation containing penciclovir
EP0593562B1 (en) Topical composition containing penciclovir
CA2022632A1 (en) Pharmaceutical formulation
US6469015B1 (en) Pharmaceutical formulation
JP2000072644A (en) Preparation for external use for skin

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19990909